T2 mapping and T2* imaging in heart failure
- PMID: 28497231
- PMCID: PMC5487811
- DOI: 10.1007/s10741-017-9616-5
T2 mapping and T2* imaging in heart failure
Abstract
Cardiovascular magnetic resonance (CMR) is a versatile imaging modality that enables aetiological assessment and provides additional information to that of standard echocardiography in a significant proportion of patients with heart failure. In addition to highly accurate and reproducible assessment of ventricular volumes and replacement fibrosis, multiparametric mapping techniques have rapidly evolved to further expand the diagnostic and prognostic applications in various conditions ranging from acute inflammatory and ischaemic cardiomyopathy, to cardiac involvement in systemic diseases such as sarcoidosis and iron overload cardiomyopathy. In this review, we discuss the established role of T2* imaging and rapidly evolving clinical applications of myocardial T2 mapping as quantitative adjuncts to established qualitative imaging techniques.
Keywords: Inflammatory cardiomyopathy; Iron overload; Myocarditis; Sarcoidosis; T2 mapping; Transplant rejection.
Conflict of interest statement
Funding
ASL is supported by the Alexander Jansons Foundation and British Heart Foundation [FS/17/21/32712].
Conflict of interest
The authors declare that they have no conflicts of interest.
Figures
References
-
- Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O’Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908. doi: 10.1001/jama.2013.1363. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
